Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar-Reference-Cited by-同舟云学术

Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar

Published:2016-12-31 Issue:3 Volume:33 Page:439-458
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Deleu Dirk¹,Mesraoua Boulenouar¹,El Khider Hisham¹,Canibano Beatriz¹,Melikyan Gayane¹,Al Hail Hassan¹,Mhjob Noha¹,Bhagat Anjushri¹,Ibrahim Faiza¹,Hanssens Yolande²

Affiliation:

1. Department of Neurology, Neuroscience Institute, Hamad Medical Corporation, Doha, State of Qatar;

2. Department of Clinical Services Unit, Pharmacy, Hamad Medical Corporation, Doha, State of Qatar

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1261818

Reference181 articles.

1. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

2. Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis

3. Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis

4. Frequency and clinical patterns of multiple sclerosis in Arab countries: A systematic review

5. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis;Drug Development Research;2021-02-15

3. Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study;Case Reports in Women's Health;2020-01

4. Management of relapsing–remitting multiple sclerosis in Qatar: an expert consensus;Current Medical Research and Opinion;2019-10-07

5. Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis;Autoimmunity Reviews;2019-05